🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A win for people with BRAF altered low grade glioma! fda.gov/drugs/resource…

Wonderful science at the Johns Hopkins Kimmel Cancer Center #younginvestigatorday with @AbiolaAyanlaja Maria Ioannou

I was so fortunate to train under Mark Gilbert at NIHBrainTumor during fellowship. Thank you for all you've done for our field and our patients!

Great opportunity at a busy clinical and research program. DM me if interested!

I learned so much from this ASCO project with @MartinvdenBent and Dr. Mellinghoff Memorial Sloan Kettering Cancer Center. Thank you Lauren Schaff, MD Marjolein Geurts and Maria Ioannou! ascopubs.org/doi/10.1200/ED…

I just had an insurance company deny #tovorafenib (#Ojemda) for a patient with BRAF-fusion recurrent pilocytic astrocytoma because it wasn't a "pediatric low grade glioma". Pediatric Brain Tumor Consortium Pediatric Brain Tumor Foundation Day One Biopharmaceuticals any recommendations/ resources on how to educate insurance companies?

#NFAwareness month at the Johns Hopkins Medicine dome tonight and all month! So thankful for the work so many brilliant people are doing here to #cureNF Johns Hopkins Kimmel Cancer Center Neurofibromatosis Therapeutic Acceleration Program

So excited to support Sandra Misale and KRASKickers at Johns Hopkins Kimmel Cancer Center ! Please join!

Exciting to see the Nature Communications real-world report on #CeGaT peptide vaccine in ppl with #GBM. Now for a prospective trial! nature.com/articles/s4146…

Nice work Dr. Bazer! So important to think about dose modification for toxicity and the impact of holding #BRAF targeted therapy for #glioma patients: academic.oup.com/nop/article/11… Johns Hopkins Kimmel Cancer Center UCSF Neurosurgery

Proud to report our group effort with Mustafa Khasraw (find me in BlueSky) & the SNO #Biospecimen WG promoting multiple biopsies in clinical trials is public in The Lancet Oncology. We need to push the envelope on trial design if we are going to change the paradigm for #GBM authors.elsevier.com/c/1jsBK5EIIgPd…

Wonderful collaboration with CJ Lucas, MD and the Neuro-Onc Precision Medicine Group Johns Hopkins Kimmel Cancer Center to understand the effect of NF1 loss on sporadic #GBM co-muts and survival. Johns Hopkins Neuro-Oncology Surgical Outcomes Lab Jordina Rincon-Torroella Fausto Rodriguez Maria Ioannou actaneurocomms.biomedcentral.com/articles/10.11…

Great to see this collaborative effort come to fruition! Thank you Lucy Chen, Peng Huang, CJ Lucas, MD Johns Hopkins Neuro-Oncology Surgical Outcomes Lab Jordina Rincon-Torroella, this was a team effort! #Gliosarcoma #GBM Johns Hopkins Kimmel Cancer Center